Rojuzda 25mg injection contains an active component as Luspatercept. It is a medication that has been developed for the treatment of certain types of anemia. Specifically, it treats anemia associated with two rare blood disorders: beta-thalassemia and myelodysplastic syndromes (MDS). Beta-thalassemia is an inherited blood disorder that affects the production of hemoglobin, the protein responsible for carrying oxygen in red blood cells. Myelodysplastic syndromes (MDS) are a group of bone marrow disorders characterized by ineffective blood cell production. One of the primary benefits of this medication is its ability to reduce the frequency of blood transfusions in patients with anemia associated with beta-thalassemia and MDS.

Rojuzda 25mg injection should not be used in individuals who have a known hypersensitivity or allergic reaction to the medication or any of its components. It may increase the risk of blood clot formation. Suppose you have a history of blood clots or are at an increased risk for clotting disorders. In that case, your healthcare provider should carefully evaluate the potential risks and benefits of Rojuzda 25mg injection treatment. Tell your healthcare provider before taking it if you have any other medical conditions or are undergoing treatments.

Beta-thalassemia.

Myelodysplastic syndromes.

Rojuzda 25mg injection is a medication with a therapeutic effect that promotes red blood cell production and reduces the need for blood transfusions in individuals with beta-thalassemia and myelodysplastic syndromes (MDS). By targeting proteins involved in regulating red blood cell formation, this medication stimulates the production of mature red blood cells, leading to increased hemoglobin levels and improved oxygen-carrying capacity. This not only reduces the frequency of blood transfusions but also enhances the quality of life by alleviating fatigue and improving overall well-being. Additionally, it may have disease-modifying effects, potentially mitigating organ complications associated with chronic anemia.

To use Rojuzda 25mg injection, follow the instructions provided by your healthcare provider or as indicated on the medication label. It is typically administered as an injection. The exact dosing and administration instructions may vary based on the specific condition being treated.

Blood clots

Hypertension (high blood pressure)

Stroke

Heart attack

Venous thromboembolism (blood clot in a vein)

Thrombosis (blood clotting disorder)

Embolism (blockage of blood vessels by a clot or other substance)

Hemorrhage (excessive bleeding)

Allergic reactions (rare, but may include rash, itching, swelling, severe dizziness, or difficulty breathing)

Headache

Fatigue

Dizziness

Nausea

Joint pain

Bone pain

Muscle pain

Injection site reactions (e.g., pain, redness, swelling)

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Rojuzda 25mg injection, reducing effectiveness by causing undesirable side effects.

Stored in the refrigerator at a temperature between 2°C to 8°C (36°F to 46°F).

Keep away from moisture, heat, and light.

It should not be frozen.

Keep away from children and pets.

To ensure the safe and effective use of Rojuzda 25mg injection, it is important to approach its use with caution and adhere to the advice given by the healthcare provider. Regular monitoring of blood pressure, liver function, kidney function, and iron levels is typically recommended during treatment. Any abnormalities or changes in these parameters should be promptly addressed and managed accordingly. Individuals with a history of blood clots, clotting disorders, or significant bleeding episodes should be closely monitored during treatment due to the increased risk of thrombotic events and hemorrhage. It is important to promptly report any signs of bleeding, such as unusual bruising, nosebleeds, or blood in the urine or stool, to your healthcare provider. You should discuss the potential risks of this medication during pregnancy or breastfeeding with your healthcare provider and communicate openly with your healthcare provider about your medical history, ongoing treatments, and any concerns you may have. By being proactive and informed and maintaining regular communication with your healthcare provider, you can maximize the benefits of this medicine while minimizing potential risks.